Tru-Vu Wrist Positioning Aid Multi-Center Implementation Within NLHS

May 13, 2026 updated by: Emily Lalone, Western University

This study has two primary aims: 1) to determine whether a novel wrist x-ray positioning aid can be implemented within 3 different healthcare centers in Newfoundland and Labrador, and 2) to determine the ability of the tool to improve patient positioning in wrist x-rays. It will also learn about the number of repeat x-rays required with or without the use of the tool and radiographer confidence. The main questions it aims to answer are:

  1. Will the implementation of the Tru-Vu differ between an urban health center, rural clinic, and remote regional hospital?
  2. Can the Tru-Vu improve the positioning procedure for radiographers performing wrist x-rays, resulting with more useful x-rays.

Researchers will compare x-rays before and after the implementation of the tool as well as between centers.

Technologist participants will:

  • Use the tool during the positioning procedure for wrist x-rays.
  • Provide feedback regarding tool use and perceived implementation barriers and facilitators.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

1800

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Canada
    • Labrador
      • Happy Valley-Goose Bay, Labrador, Canada, A0P1C0
        • Labrador Health Centre
        • Contact:
    • Newfoundland and Labrador
      • Norris Point, Newfoundland and Labrador, Canada, A8A3L1
        • Bonne Bay Health Centre
        • Contact:
      • St. John's, Newfoundland and Labrador, Canada, A1B3V6
        • Health Sciences Centre
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Must be 18 years of age or older
  • Must be proficient in English (reading/writing)
  • Must have been referred for wrist imaging at one of the following healthcare centers: Health Sciences Center (St. John's, NL), Bonne Bay Health Center (Norris Point, NL), or Labrador Health Center (Happy Valley-Goose Bay, NL).

Exclusion Criteria:

  • Incapable of providing informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Urban hospital
Radiographs will be retrospectively collected and compared to radiographs captured after the implementation of the tool. Additional radiographs will be collected over a 6-month follow-up period.
Device: Tru Vu tool and training
A positioning aid and training videos for wrist x-rays
Experimental: Rural health center
Radiographs will be retrospectively collected and compared to radiographs captured after the implementation of the tool. Additional radiographs will be collected over a 6-month follow-up period.
Device: Tru Vu tool and training
A positioning aid and training videos for wrist x-rays
Experimental: Regional remote hospital
Radiographs will be retrospectively collected and compared to radiographs captured after the implementation of the tool. Additional radiographs will be collected over a 6-month follow-up period.
Device: Tru Vu tool and training
A positioning aid and training videos for wrist x-rays

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiograph grading score
Time Frame: Radiographs will be collected retrospectively 4 months prior to implementation and 6 months prospectively after the implementation of the tool.
Radiographs collected retrospectively and prospectively will be graded by a radiologist and radiographer
Radiographs will be collected retrospectively 4 months prior to implementation and 6 months prospectively after the implementation of the tool.
Tool adoption (and associated implementation outcomes)
Time Frame: The survey will be administered 6 months after the implementation of the tool and training.
A survey will collect perceived tool use and other perceived implementation outcomes (including fidelity, appropriateness, acceptability, and adoption).
The survey will be administered 6 months after the implementation of the tool and training.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sustainability
Time Frame: 6 months after the conclusion of the implementation period
Post-follow up survey will be conducted 6 months after the end of the implementation period and will collect perceived tool use.
6 months after the conclusion of the implementation period
Repeated radiographs
Time Frame: Repeat radiographs will be collected and compared 4 months retrospectively prior to implementation and 6 months after the start of implementation.
Document the number of repeat radiographs captured.
Repeat radiographs will be collected and compared 4 months retrospectively prior to implementation and 6 months after the start of implementation.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Western University

Collaborators

Newfoundland Health Services
NLHS

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 14, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

September 1, 2027

Study Registration Dates

First Submitted

May 5, 2026

First Submitted That Met QC Criteria

May 5, 2026

First Posted (Actual)

May 12, 2026

Study Record Updates

Last Update Posted (Actual)

May 18, 2026

Last Update Submitted That Met QC Criteria

May 13, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 129141

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthritis

Clinical Trials on Tru Vu tool and training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe